Evolution of interventional cardiology in China

( views:, downloads: )
Author:
SHEN Wei-feng(Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine)
Journal Title:
CHINESE MEDICAL JOURNAL
Issue:
Volume 122, Issue 19, 2009
DOI:
10.3760/cma.j.issn.0366-6999.2009.19.002
Key Word:

Abstract:

  • [1]National Center for Cardiovascular Diseases,China.Report on cardiovascular disease in China (2007).Beijing:Encyclopedia of China Publishing House; 2007:154.
  • [2]Lü SZ,Song XT,Chen YD,on behalf of investigators of Chinese Coronary Intervention Registry.Findings from registry of percutaneous coronary intervention in inland of China.Chin J Cardiol (Chin) 2009; 37:26-29.
  • [3]Gao RL.Current status and perspective of percutaneous coronary intervention in China.Chin Med J 2006; 119; 531-532.
  • [4]Shen WF.Interventional therapy of coronary artery disease in China:retrospective and perspective.Chin Med J 2009; 121:2336-2341.
  • [5]Chinese Society of Cardiology,Chinese Journal of Cardiology.Guidelines for percutaneous coronary intervention.Chin J Cardiol (Chin) 2002; 30:707-718.
  • [6]Chinese Society of Cardiology,Editorial Board of Chinese Journal of Cardiology.Guidelines for percutaneous coronary intervention (2009).Chin J Cardiol (Chin) 2009; 37:4-25.
  • [7]Song L,Hu DY,Yan HB,Yang JG,Sun YH,Chao L,et al.Influence of ambulance use on early reperfusion therapies for acute myocardial infarction.Chin Med J 2008; 121:771-775.
  • [8]Collaborative Research Group.Randomized controlled trial comparing small dose of recombinant tissue-type plasminogen activator with full dose of urokinase in Chinese patients with acute myocardial infarction.Chin J Cardiol (Chin) 1999; 27:174-179.
  • [9]Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.A randomized multicenter trial comparing recombinant staphylokinase with recombinant tissue-type plasminogen activator in patients with acute myocardial infarction.Chin J Cardiol (Chin) 2007; 35:691-696.
  • [10]Zhang Q,Zhang RY,Jin HG,Qiu JP,Chen YH,Wang XL,et al.Impact of different clinical pathways on outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention:the RAPID-AMI study.Chin Med J 2009; 122:636-642.
  • [11]Zhang Q,Zhang RY,Qiu JP,Zhang JF,Wang XL,Jiang L,et al.Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.Chin Med J 2008; 121:485-491.
  • [12]Shen J,Zhang Q,Zhang RY,Zhang JS,Hu J,Yan ZK,et al.Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.Coron Artery Dis 2008; 19:271-277.
  • [13]Fu XH,Hao QQ,Jia XW,Fan WZ,Gu XH,Wu WL,et al.Effect of tirofiban plus clopidogrel and aspirin on primary percutaneous coronary intervention via transradial approach in patients with acute myocardial infarction.Chin Med J 2008; 121:522-527.
  • [14]Gao RL.Shortening the door-to-balloon time for transferring primary percutaneous coronary intervention:physician transfer may be a better way in China.Chin Med J 2008; 121:483-484.
  • [15]Bassand JP.Management of non ST segment elevation acute coronary syndromes:A shift in the paradigm.Chin Med J 2008; 121:3-5.
  • [16]Bi YF,Gao RL,Patel A,Su S,Gao W,Hu DY,et al on behalf of the CPACS investigators.Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization:Results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.Am Heart J 2009; 157:509-516.
  • [17]Ma HY,Zhou YJ,Dick RJ,Shi DM,Liu YY,Cheng WJ,et al.Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting:a comparison of bare metal stent and drug eluting stent.Chin Med J 2008; 121:887-891.
  • [18]Yan ZX,Zhou YJ,Zhao YX,Liu YY,Shi DM,Guo YH,et al.Safety and feasibility of transradial approach for primary percutaneous coronary intervention in elderly patients with acute myocardial infarction.Chin Med J 2008; 121:782-786.
  • [19]Shen WF.Screening for coronary artery disease in asymptomatic patients with type 2 diabetes mellitus.Chin Meal J 2007; 120:1859-1861.
  • [20]Yang YJ,Xu B,Kang S,Pei WD,Chen JL,Qiao SB,et al.Comparison of in-hospital and long-term outcomes between a Cypher stent and a Taxus stent in Chinese diabetic patients with coronary artery disease.Chin Med J 2007; 120:1868-1873.
  • [21]Zhang Q,Shen J,Zhang RY,Lu JD,Zhang Y,Zhen YH,et al.Outcomes after primary coronary intervention with drug-eluting stent implantation in diabetic patients with acute ST elevation myocardial infarction.Chin Med J 2007; 120:1862-1867.
  • [22]Li Y,Zheng Z,Xu B,Zhang SJ,Li W,Gao RL,et al.Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease:Three-year follow-up results from a single institution.Circulation 2009; 119:2040-2050.
  • [23]Zhang RY,Ni JW,Zhang JS,Hu J,Yang ZK,Zhang Q,et al.Long term clinical outcomes in patients with moderate renal insufficiency undergoing stent based percutaneous coronary intervention.Chin Med J 2006; 119:1176-1181.
  • [24]Zhang RY,Zhu ZB,Zhang Q,Yang ZK,Hu J,Lü AK,et al.Impact of moderate or severe renal insufficiency on long-term outcomes in patients undergoing drug-eluting stent based coronary intervention.Int J Cardiol 2009; 136:72-79.
  • [25]Zhu ZB,Zhang RY,Zhang Q,Zhang JS,Hu J,Yang ZK,et al.Moderate to severe renal insufficiency is a risk factor for sirolimus-eluting tent thrombosis.The RIFT Study.Cardiology 2009; 112:1911-1919.
  • [26]Gao RL,Xu B,Chen JL,yang YJ,Qiao SB,Li JJ,et al.Immediate and long-term outcomes of drug-eluting stent implantation for unprotect left main coronary artery disease:comparison with bare-metal stent implantation.Am Heart J 2008; 155:553-561.
  • [27]Chen JL,Gao RL,Yang YJ,Qiao SB,Qin XW,Yao M,et al.Short and long-term outcomes of two drug eluting stents in bifurcation lesions.Chin Med J 2007; 120:183-186.
  • [28]Chen SL,Zhang JJ,Ye E Chen YD,Patel T,Kawajiri K,et al.Study comparing the double kissing (DK) crush with classic crush for the treatment of coronary bifurcation lesions:the DKCRUSK-1 Bifurcation Study with drug-eluting stents.Eur J Clin Invest 2008; 38:361-371.
  • [29]Chen SL,Zhang JJ,Ye E Chen YD,Zhu ZS,Lin S,et al.Crush stenting in treating coronary bifurcation lesions:paclitexel eluting stents versus sirolimus eluting stents.Chin Med J 2008; 121:528-533.
  • [30]Han YL,Wang SL,Jing QM,Li Y,Zhang J,Ma YY,et al.Percutaneous coronary intervention for chronic total occlusion in 1263 patients:a single-center report.Chin Med J 2006; 119:1165-1170.
  • [31]Qian JY.Detection of vulnerable plaques rather than the culprit lesions in patients with acute coronary syndrome using virtual histology intravascular ultrasound imaging.Chin Meal J 2009; 122:610-611.
  • [32]Tian E Chen YD,Sun ZJ,Chen L,Yuan F,Song XT,et al.Evaluation of neointimal coverage of overlapping sirolimus-ehiting stents by optical coherence tomography.Chin Med J 2009; 122:670-674.
  • [33]Gao RL,Xu B,Lü SZ,Chen JL,Han YL,Chen JZ,et al.Safety and efficacy of the CYPHER selected sirolimus-eluting stent in the "Real World"-clinical and angiographic results from the China CYPHER select registry.Int J Cardiol 2008; 125:339-346.
  • [34]Qian JY,Zhang E Fan B,Ge L,Wang QB,Ge JB.A more than 2-year follow-up of incomplete apposition after drug-eluting stent implantation.Chin Med J 2008; 121:498-502.
  • [35]Rao XX,Huang ZD.Current status of rheumatic heart disease in China.Chin J Cardiol (Chin) 1998; 26:98-100.
  • [36]Chen CR,Chen JY,Huang ZD.Percutaneous balloon mitral valvuloplasty (PBMV).Chin J Cardiol (Chin) 1986; 14:321-323.
  • [37]Chen CR,Hu SW,Chen JY,Zhou YL,Mei J,Cheng TO.Percutaneous mitral valvuloplasty with a single rubber-nylon balloon (Inoue balloon):long-term results in 71 patients.Am Heart J 1990; 120:561-568.
  • [38]Chen CR,Cheng TO,Chen JY,Zhou YL,Mei J,Ma TZ.Percutaneous balloon mitral valvuloplasty for mitral stenosis with and without aortic regurgitation.Am Heart J 1993; 125:128-137.
  • [39]Chen CR,Cheng TO,Chen JY,Huang YG,Huang T,Zhang B.Long-term results of percutaneous balloon mitral valuloplasty for mitral stenosis:a follow-up study to 11 years in 202 patients.Cathet Cardiovasc Diagn 1998; 43:132-139.
  • [40]Dixon SR,Grines CL,O'Neill WW.The year in interventional cardiology.J Am Coll Cardiol 2009; 53:2080-2097.
  • [41]Bai Y,Zong GJ,Wang YY,Jiang HB,Li WP,Wu H,et al.Percutaneous aortic valve replacement using a W-mode valved stent:a preliminary feasibility study in sheep.Chin Med J 2009; 122:655-658.
  • [42]Zong GJ,Bai Y,Jiang HB,Li WE Wu H,Zhao XX,et al.Use of a novel valve stent for transcatheter pulmonary valve replacement:an animal study,J Thorac Cardiovasc Surg 2009; 137:1363-1369.
  • [43]Bai Y,Zong GJ,Wang HR,Jiang HB,Wang H,Wu H,et al.An integrated pericardial valved stent special for percutaneous tricuspid implantation:An animal feasibility study.J Surg Res 2008; Nov 29 Epub ahead of print
  • [44]Yang XY,Li XD,Liu YL.Incidence of congenital heart disease in Beijing,China.Chin Med J 2009; 122:1128-1132.
  • [45]National Center for Cardiovascular Diseases,China.Report on cardiovascular disease in China (2005).Beijing:Encyclopedia of China Publishing House; 2005:100-103.
  • [46]Zhou AQ.The present and future of interventional catheterization for congenital heart disease.Chin Med J 2001; 1145:451-452.
  • [47]Dai RE Advances in interventional therapy for congenital heart disease in China.Chin J Evid Vased Cardiovasc Med (Chin) 2009; 1:68-69.
  • [48]Hu SS.One-stop hybrid approach for cardiovascular disease:from concept to practice.Ann Thorac Cardiovasc Surg 2008; 14:345-346.
  • [49]Hu DY,Chert X,Ma CS,Liu XP,on behalf of Chinese Association of Biomedical Engineering,Cardiac Pacing and Electrophysiology Branch.National survey on radiofrequency catheter ablation in China.Chin J Cardiac Arrhyth (Chin) 2002; 6:124-124.
  • [50]Wang CX,Ma CS,Yang YZ,Huang DJ,Zhang S,Jiang H,et al,on behalf of Collaborative Working Group of Management of Atrial Fibrillation.Current knowledge and management recommendations of atrial fibrillation.Chin J Cardiac Arrhyth (Chin) 2006; 10:167-197.
  • [51]Tang K,Ma J,Zhang S,Chu JM,Wang FZ,Zhang KJ,et al.Unipolar electrogram in identification of successful targets for radiofrequency catheter ablation of focal atrial tachycardia.Chin Med J 2003; 116:1455-1458.
  • [52]Liu XE Dong JZ,Mavrakis HE,Hu FL,Long DY,Fang DE et al.Achievement of pulmonary vein isolation in patients undergoing circumferential pulmonary vein ablation:A randomized comparison between two different isolation approaches.J Cardiovascular Electrophysiol 2006; 17:1263-1270.
  • [53]Long WY,Li XB,Quan X,Ma JX,Zhang P,Xu Y,et al.Focal atrial tachycardia originating from the left atrial appendage:Electrocardiographic and electrophysiologic characterization and long-term outcomes of radiofrequency ablation.J Cardiovasc Electrophysiol 2007; 18:459-464.
  • [54]Zheng LH,Yao Y,Zhang S,Chert WS,Zhang KJ,Wang FZ,et al.Organized left atrial tachyarrhythmia during stepwise linear ablation for atrial fibrillation.J Cardiovasc Electrophysiol 2009; 20:499-506.
  • [55]Liu XP,Long DY,Dong JZ,Liu XQ,Fang DP,Hao P,et al.Recurrent atrial tachycardia and atrial fibrillation after circumferential pulmonary vein ablation:What's the difference? Chin Med J 2005; 118:1773-1778.
  • [56]Tamg K,Ma J,Zhang S,Chu JM,Zhang KJ,Wang FZ,et al.Radiofraquency catheter ablation at the left coronary cusp in treatment of repetitive monomorphic tachycardia of the left ventricular outflow tract.Chin Meal J 2004; 117:168-171.
  • [57]Ma FS,MA J,Tang K,Hart H,Jia YH,Fang PH,et al.Left posterior fascicular block:a new endpoint of ablation for verapamil-sensitive idiopathic ventricular tachycardia.Chin Med J 2006; 119:367-372.
  • [58]Zou JG,Cao KJ,Chen ML,Yang B,Zhu L,Li WQ,et al.Endocardial mapping and ablation of tachyeardia guided by noncontact balloon catheter mapping system.Chin Med J 2002; 115:909-913.
  • [59]Li YG,Wang QS,Gronefeld G,Israel C,Lu SB,Shao Y,et al.Refinement of CARTO-guided substrate modification in patients with ventricular tachycardia after myocardial infarction.Chin Med J 2008; 121:122-127.
  • [60]Li YG,Grtnefeld G,Israel C,Lu SB,Wang QS,Meng S,et al.Stepwise approach to substrate modification of ventficular tachycardia after myocardial infarction.Chin Med J 2006; 119:1182-1189.
  • [61]Wu XY,Liang ZG,Tan Z,Gu HY,Zhang S,Li WM.Radiofrequency catheter ablation of idiopathic ventricular tachycardia and symptomatic premature ventricular contraction originating from valve annulus.Chin Med J 2008; 121:2241-2245.
  • [62]Yao Y,Zhang S,He DS,Zhang K,Hua W,Chu J,et al.Radiofrequency ablation of the ventricular tachycardia with arrhythmogenic right ventricular cardiomyopathy using non-contact mapping.Pacing Clin Electrophysiol 2007; 30:526-533.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn